Clovis cashes in on ASCO boom with $170m offering
This article was originally published in Scrip
Executive Summary
Clovis Oncology has announced a public offering to raise $170m on the back of the company's huge share price rise following its presentation at the American Society of Clinical Oncology annual meeting in Chicago 3 June.